{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:55:36Z","timestamp":1765904136761,"version":"3.48.0"},"reference-count":0,"publisher":"Tunisian Society of Medical Sciences","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tunis Med"],"abstract":"<jats:p>Background: Chronic heart failure (CHF) is a global and increasing problem responsible of uncontrolled rates of mortality and readmission. A therapeutic Unit of heart failure (TUNI-HF) was established to assume a treatment optimization, comorbidities management and education in order to improve heart failure (HF) prognosis.\nAim: This study aimed to describe the impact of the TUNI-HF on treatment optimization, mortality and readmission rates at 12 months in patients with heart failure with reduced ejection fraction (HFrEF).\nMethods: \u00a0A retrospective study was conducted in the military hospital of Tunis, Tunisia. Two groups were compared: Group \u201cC\u201d included patients followed from March 2018 for 12 months with usual care. Group \u201cU\u201d included patients followed from Mars 2021 for 12 months in the TUNI-HF.\nResults: Groups \u201cC\u201d and \u201cU\u201d enrolled 108 and 110 patients respectively. At baseline, patients\u2019 characteristics were comparable. Prescription rates of guideline directed medical treatment (GDMT) at optimal doses were low in two groups. After 12 months, prescription rates of beta-blockers (BB) and mineralocorticoid receptor antagonist (MRA) were higher in group \u201cU\u201d. In addition, optimal doses of BB, renin angiotensin aldosterone system inhibitors (RAASI) and MRA were more achieved in the same group \u201cU\u201d. Loop diuretics were less prescribed in the group \u201cU\u201d and cardiac implantable devices rate was higher in the same group. Kaplan Meier analysis showed significantly lower rates of readmission and all-cause mortality rates in the group \u201cU\u201d.\nConclusion: The management of HF in a specialized unit, compared with usual care,...(abstract truncated at 250 words).<\/jats:p>","DOI":"10.62438\/tunismed.v103i6.5449","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:53:09Z","timestamp":1765903989000},"source":"Crossref","is-referenced-by-count":0,"title":["Enhanced Heart Failure Management: Impact of the therapeutic unit for heart failure (TUNI-HF) on mid-term prognosis"],"prefix":"10.62438","volume":"103","author":[{"given":"Houdhayfa","family":"Hermassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houssem","family":"Ben Ayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houaida","family":"Mahfoudhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadhem","family":"Nadhem Hajlaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdedayem","family":"Haggui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafa","family":"Fehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"31112","published-online":{"date-parts":[[2025,6,1]]},"container-title":["La Tunisie M\u00e9dicale"],"original-title":[],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:53:10Z","timestamp":1765903990000},"score":1,"resource":{"primary":{"URL":"https:\/\/latunisiemedicale.com\/index.php\/tunismed\/article\/view\/5449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.62438\/tunismed.v103i6.5449","relation":{},"ISSN":["2724-7031","0041-4131"],"issn-type":[{"value":"2724-7031","type":"electronic"},{"value":"0041-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}